EP0005131B1 - Methods and materials for cleaning soft contact lenses - Google Patents
Methods and materials for cleaning soft contact lenses Download PDFInfo
- Publication number
- EP0005131B1 EP0005131B1 EP79850032A EP79850032A EP0005131B1 EP 0005131 B1 EP0005131 B1 EP 0005131B1 EP 79850032 A EP79850032 A EP 79850032A EP 79850032 A EP79850032 A EP 79850032A EP 0005131 B1 EP0005131 B1 EP 0005131B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- lens
- enzyme
- lipase
- solution
- cleaning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
Definitions
- the present invention relates to a method and materials for removing from soft contact lenses deposits that are formed during use.
- Such deposits contain mainly albumin, globulins and lipids.
- Deposits that occur during use of soft contact lenses generally result in an opaque film, yellow discoloration, white spots and thread-like configurations on the lenses. Investigations carried out have shown that these deposits can consist of albumin, Ig y-globulin, Lysozyme and lipoproteins.
- the deposits are often largely composed of lipids and denatured albumin, which are deposited on the lenses from the tear fluid as a result of the saline solution with which the lenses are impregnated being exchanged for the tear fluid.
- the drying-out of a lens for instance through its use in a dry environment and by air flowing past it, etc. causes some albumin to be denatured and deposited on the lens.
- albumin is denatured which gives rise to apolar interior groups of lipids.
- Other causes too such as for example continuous use, cause albumin and lipids to be deposited on contact lenses in fairly large quantities.
- One method of cleaning contact lenses is already known which comprises the steps of dissolving in water a proteolytic enzyme in tablet form and then placing the lenses to be cleaned in the solution for a period of at least two hours.
- This process has been regarded as complicated by the wearers of contact lenses so that cleaning has not always been carried out as regularly as is required and this has resulted in lenses finally acquiring such a coating that the lenses have become unusable.
- the prior art using only proteolytic enzymes does not provide for complete removal of the deposits formed in that deposits of lipid origin remain substantially unaffected by the solutions of the prior art.
- An object of the present invention is to provide cleaning solutions and methods for cleaning soft contact lenses which, on the one hand are simple for the contact lens wearer to use and which also provide an improved cleaning effect.
- Yet another object of the present invention is to provide solid compositions of matter to be dissolved in an aqueous vehicle to form soft contact lens cleaning solutions, preferably of a hypertonic character.
- an enzyme containing cleaning liquid for soft contact lenses consists of a solution containing a lipolytic enzyme (mainly for reducing the lipids) and a proteolytic enzyme, such as papain or bromelain, (for reducing the albumin deposits) and, additionally, a phosphate buffering agent.
- a lipolytic enzyme mainly for reducing the lipids
- a proteolytic enzyme such as papain or bromelain
- a phosphate buffering agent preferably hypertonic to its nature, i.e. its osmotic pressure exceeds that of a physiological solution, so that in treatment with the solution some dewatering of the lens takes place, which seems to be beneficial to the cleaning effect.
- an isotonic solution for example a saline solution
- the lens reversibly again takes up water to revert to its original state.
- a pack for cleaning soft contact lenses comprises a volume of a solution containing papain or bromelain and a lipolytic enzyme, a device for forming droplets of the solution for depositing same on the surface of a soft contact lens and a volume of a sterile isotonic physiological saline solution in which the lens can be rinsed and subsequently boiled.
- the method of cleaning a soft contact lens in accordance with the invention to remove deposits on the surface of the lens by enzymatic action comprises the steps of placing at least one drop of a solution containing a proteolytic enzyme, such as papain or bromelain, and in addition a lipolytic enzyme, on the contact lens which is to be cleaned to reduce both albumin and lipids present to water soluble peptones, fatty acids and esters, and subsequently removing the resulting products by rinsing and boiling the lens in a physiological saline solution.
- a proteolytic enzyme such as papain or bromelain
- the enzyme activity in the cleaning solution is of the order of 100 tyrosine units per ,ug of protein.
- the fluid activity is allowed to occur for a period of the order of 15 minutes.
- the physiological saline solution has a particle size below 0.2 microns, and is isotonic, has a pH-value of 7.0 with a buffer capacity of 6-8 and is also sterile.
- a preferred enzyme solution for cleaning the lens consists of bromelain, mannitol, sorbitol, ethylenediamine tetraacetic acid, sodium metabisulphite, and a lipolytic enzyme.
- a preferred cleaning solution may consist of: diluted to 1 litre aqua dest., together with lipase from cand. cylindracae, preferably in an amount corresponding to 50000 units, in 1000 ml. 0.1 M phosphate buffer in an aqueous polymer complex.
- aqueous polymer complex which is conventional in the art and have for a purpose to bind the lipolytic enzymes so that it will not be unduly destroyed by the proteolytic enzyme.
- the nature of this polymer complex is not critical and any commercial product may be used, such as polyethylene glycol, polyvinyl alcohol, polyvinyl pyrrolidone and the like. As a fully non-limiting example one may mention the polymer complex "Kollodon" 25 or 30 from BASF, West Germany.
- PMMA, HEMA and PvP all have a common factor, that is, they are lipid and protein retensive. New materials have been introduced such as silicone, even in this material there is lipid retention.
- the lipid deposits appear either as yellowish tinting of the lens or as a whitish haze.
- the deposits are composed of phospholipids, probably in the form of lecitin, forming together with the protein a lecitoprotein, (lecitin on exposure to heat and light tends to autooxidise or decompose into yellowish substances) or cholesterol and fat esters which are white in colour.
- plaque consists of a central core of lipid lying free on the polymer and protruding into the material matric causing a sand grain sensation when the lens lies in the eye.
- any lipolytic enzyme hydrolyzing the lipids to yield fatty acids and glycerol are useful.
- a preferred variety is lipase derived from cand. cylindracae, suitably prepared by lyophilization.
- a proteolytic enzyme any protein- digesting enzyme is useful, preferred examples being bromelain and papain.
- a lipolytic enzyme and a proteolytic enzyme the latter being papain, it will be noted that the beneficial effect of free sulfhydryl groups on the activity of papain will be satisfied by the presence of the lipase containing sulfhydryl groups.
- such combination of enzymes is particularly preferred, especially when used in solutions of a hypertonic character.
- a soft contact lens cleaning fluid (known as Prolen) is made up as follows: Then add:-Lipase from cand. cylindracae 50000 units in 1000 ml 0.1 M Phosphate buffer in an aqueous polymer complex.
- a few drops (0.3 ml) of the fluid are placed on a lens and left on the lens for 15 minutes.
- the lens is then rinsed in a saline solution and thereafter boiled in the saline solution for 20 minutes. Finally the lens is rinsed once more in the saline solution before reinserting.
- a lens is usually coated with deposits of protein, lipoproteins and lipids.
- the lens is treated with a preparation having a high enzymatic effect which contains a stabilised protease and a high activity lipase. Drops of the preparation are placed on the lens in accordance with the invention and it is left for the preparation to take effect, for 15 minutes.
- This cleaning preparation is, as described above, preferably formed from Bromelain, Mannitol, Sorbitol, Ethylenediaminetetraacetic acid, Sodium Metabisulphate and lipolytic enzyme.
- Complete removal of lipids from the lens is achieved by using a stabilised enzyme in fluid form and this may be applied either separately or as a second step. This is typically dripped onto the contact lens so as to remove any lipid deposits.
- the stabilised enzyme in fluid form is, as described above, preferably a lipase with a phosphate buffer.
- a further step in the cleaning operation involves rinsing the contact lens in a physiological saline solution and then boiling the lens in the same or a similar solution.
- the saline solution sould be particle-free (i.e. have a particle size below 0.2 micron), should be isotonic, should have a pH-value of 7.0 and buffer capacity of 6-8 and should also be sterile.
- the pH-value which is indicated is that value which will avoid smarting when the lens is subsequently inserted. An incorrect pH-value will cause smarting to occur. An incorrect pH-value will also cause the protein in the tear fluid to become denatured spontaneously which is not, of course, desirable.
- the solution is preferably packed in a disposable pack and is sterilised by means of Gamma radiation.
- the fluid consists of Lysozyme, Ig y-gobulin, 1-lipoprotein, small amounts of carbohydrates and phospholipids.
- a similar solution was therefore prepared from the following:- y-chymotrypsin, serum albumin, lysozyme, bovine mucin, globulin II, A-globulin III, globulin and A-lipoprotein in 0.9% NaCI solution. Lenses were placed in this prepared solution and left over night. Control lenses were kept in a sterile saline solution instead of the prepared solution. At the end of the period of storage the lenses were divided into four groups:-
- the invention allows soft contact lenses to be cleaned rapidly and effectively and in general the cleaning operation should be carried out daily. However, where lenses are worn day and night, the interval between cleanings may be extended to every other or even every third day.
- the invention therefore provides for a simpler cleaning process than the known technique which requires the dissolving of tablets in water and also provides for a shorter cleaning period than hitherto. What is more important, however, is that the invention allows a more complete cleaning of the contact lens on account of the higher enzymatic activity. Unlike previously known cleaning preparations, the method according to the present invention is also designed to be used daily on the one hand for cleaning the lenses and on the other hand as a preventative measure to prevent the build-up of larger deposits of protein and lipids which after a time are difficult to remove and affect the properties of the lens.
- the types of enzymes which can be utilised may be Papain or Bromelain in each case together with a lipolytic enzyme. Cysteine and Polysaccharides may be used as substrate materials.
- Enzymatic activity should be of the order of 100 tyrosine units per p g of protein (substrate).
- the albumin By splitting the albumin into water-soluble peptones by enzymatic action, the latter can be rinsed or boiled away using a physiological saline isotonic solution.
- the invention provides a stable liquid cleaning agent for cleaning soft contact lenses which can be stored under normal environmental conditions without loss of enzymatic activity thereby obviating the need to dissolve a tablet or quantity of powder in water so as to produce the cleaning solution for the lens.
- the invention provides for the application of the cleaning liquid by means of droplet applicator or the like.
- the Prolen solution described above is used as a regular daily cleaning agent. This will remove most of the deposits normally found on the lens but will not completely remove the Lipid deposits.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Detergent Compositions (AREA)
- Eyeglasses (AREA)
Description
- The present invention relates to a method and materials for removing from soft contact lenses deposits that are formed during use. Such deposits contain mainly albumin, globulins and lipids.
- Deposits that occur during use of soft contact lenses generally result in an opaque film, yellow discoloration, white spots and thread-like configurations on the lenses. Investigations carried out have shown that these deposits can consist of albumin, Ig y-globulin, Lysozyme and lipoproteins.
- The deposits are often largely composed of lipids and denatured albumin, which are deposited on the lenses from the tear fluid as a result of the saline solution with which the lenses are impregnated being exchanged for the tear fluid. The drying-out of a lens, for instance through its use in a dry environment and by air flowing past it, etc. causes some albumin to be denatured and deposited on the lens. Even when contact lenses are sterilized by boiling, albumin is denatured which gives rise to apolar interior groups of lipids. Other causes too, such as for example continuous use, cause albumin and lipids to be deposited on contact lenses in fairly large quantities.
- One method of cleaning contact lenses is already known which comprises the steps of dissolving in water a proteolytic enzyme in tablet form and then placing the lenses to be cleaned in the solution for a period of at least two hours. This process has been regarded as complicated by the wearers of contact lenses so that cleaning has not always been carried out as regularly as is required and this has resulted in lenses finally acquiring such a coating that the lenses have become unusable. Moreover, the prior art using only proteolytic enzymes does not provide for complete removal of the deposits formed in that deposits of lipid origin remain substantially unaffected by the solutions of the prior art.
- An object of the present invention is to provide cleaning solutions and methods for cleaning soft contact lenses which, on the one hand are simple for the contact lens wearer to use and which also provide an improved cleaning effect.
- It is another object to provide cleaning liquids which prevent a general build-up of proteins and lipids.
- Yet another object of the present invention is to provide solid compositions of matter to be dissolved in an aqueous vehicle to form soft contact lens cleaning solutions, preferably of a hypertonic character.
- According to one aspect of the invention an enzyme containing cleaning liquid for soft contact lenses consists of a solution containing a lipolytic enzyme (mainly for reducing the lipids) and a proteolytic enzyme, such as papain or bromelain, (for reducing the albumin deposits) and, additionally, a phosphate buffering agent. Such cleaning liquid is preferably hypertonic to its nature, i.e. its osmotic pressure exceeds that of a physiological solution, so that in treatment with the solution some dewatering of the lens takes place, which seems to be beneficial to the cleaning effect. During aftertreatment with an isotonic solution, for example a saline solution, the lens reversibly again takes up water to revert to its original state.
- A pack for cleaning soft contact lenses comprises a volume of a solution containing papain or bromelain and a lipolytic enzyme, a device for forming droplets of the solution for depositing same on the surface of a soft contact lens and a volume of a sterile isotonic physiological saline solution in which the lens can be rinsed and subsequently boiled.
- The method of cleaning a soft contact lens in accordance with the invention to remove deposits on the surface of the lens by enzymatic action comprises the steps of placing at least one drop of a solution containing a proteolytic enzyme, such as papain or bromelain, and in addition a lipolytic enzyme, on the contact lens which is to be cleaned to reduce both albumin and lipids present to water soluble peptones, fatty acids and esters, and subsequently removing the resulting products by rinsing and boiling the lens in a physiological saline solution.
- Preferably the enzyme activity in the cleaning solution is of the order of 100 tyrosine units per ,ug of protein.
- The fluid activity is allowed to occur for a period of the order of 15 minutes.
- Preferably the physiological saline solution has a particle size below 0.2 microns, and is isotonic, has a pH-value of 7.0 with a buffer capacity of 6-8 and is also sterile.
- A preferred enzyme solution for cleaning the lens consists of bromelain, mannitol, sorbitol, ethylenediamine tetraacetic acid, sodium metabisulphite, and a lipolytic enzyme.
-
- In order to avoid undue interaction between the lipolytic and proteolytic enzymes it is preferable to include in the solution a so-called "aqueous polymer complex", which is conventional in the art and have for a purpose to bind the lipolytic enzymes so that it will not be unduly destroyed by the proteolytic enzyme. The nature of this polymer complex is not critical and any commercial product may be used, such as polyethylene glycol, polyvinyl alcohol, polyvinyl pyrrolidone and the like. As a fully non-limiting example one may mention the polymer complex "Kollodon" 25 or 30 from BASF, West Germany.
- In order to obtain a full understanding of the invention, its background and its underlying problems, some further explanation will be given below.
- The polymers used in the manufacturing of soft contact lenses at the present time, PMMA, HEMA and PvP all have a common factor, that is, they are lipid and protein retensive. New materials have been introduced such as silicone, even in this material there is lipid retention.
- At the present time it does not seem possible to present a material for the manufacturing of soft contact lenses that does not present this problem.
- This problem of fatty deposits from tear fluids has been demonstrated in numerous investigations. The insidious, relentless accumulation of fatty deposits on and in the matrix of the lens material can appear after a short period of time, it seems that the amount of lipids in tear fluid varies from one person to the next.
- The lipid deposits appear either as yellowish tinting of the lens or as a whitish haze.
- Chemically the deposits are composed of phospholipids, probably in the form of lecitin, forming together with the protein a lecitoprotein, (lecitin on exposure to heat and light tends to autooxidise or decompose into yellowish substances) or cholesterol and fat esters which are white in colour.
- Plaques or what one might cal lesions also appears on the lenses after a period of time. Typically the plaque consists of a central core of lipid lying free on the polymer and protruding into the material matric causing a sand grain sensation when the lens lies in the eye.
- Unfortunately, we have only theories to explain how fatty substances in the tear fluid are transformed into obstructive plaques. However, these plaques start from the same observation-an excess of lipids-and in particular cholesterol and lecitin.
- Based on these observations it is therefore quite apparent that a method for cleaning soft contact lenses presently and in the future must be one that can remove the lipid and protein deposits formed in the soft contact lens material during wearing.
- Due to the fact that new materials are being investigated it is necessary that the cleaning method must be compatible with these materials. An enzymatic method whereby a lipase is used is without doubt the most gentle method and probably the most efficient for removing fatty deposits from soft contact lenses.
- It is also evident that the greater the water content of the polymer the greater the binding of protein and lipids, this binding tends to be normally a surface adsorption but in those polymers that are combined with copolymers of certain types there is a possibility that a covalent binding can occur.
- This type of binding is naturally more difficult to separate than an ordinary surface adsorption. It is, however, possible with the use of lipase in combination with a tenside; the tenside in this case increases the water/oil interphase and allows the enzyme to react upon the lipids.
- With regard to the enzymes used in the liquid or solution according to the invention any lipolytic enzyme hydrolyzing the lipids to yield fatty acids and glycerol are useful. A preferred variety is lipase derived from cand. cylindracae, suitably prepared by lyophilization. As a proteolytic enzyme any protein- digesting enzyme is useful, preferred examples being bromelain and papain. When using in combination both a lipolytic enzyme and a proteolytic enzyme, the latter being papain, it will be noted that the beneficial effect of free sulfhydryl groups on the activity of papain will be satisfied by the presence of the lipase containing sulfhydryl groups. Thus, such combination of enzymes is particularly preferred, especially when used in solutions of a hypertonic character.
- The invention will now be further described by non-limiting examples.
-
- A few drops (0.3 ml) of the fluid are placed on a lens and left on the lens for 15 minutes. The lens is then rinsed in a saline solution and thereafter boiled in the saline solution for 20 minutes. Finally the lens is rinsed once more in the saline solution before reinserting.
- After use a lens is usually coated with deposits of protein, lipoproteins and lipids. In accordance with the invention the lens is treated with a preparation having a high enzymatic effect which contains a stabilised protease and a high activity lipase. Drops of the preparation are placed on the lens in accordance with the invention and it is left for the preparation to take effect, for 15 minutes.
- This cleaning preparation is, as described above, preferably formed from Bromelain, Mannitol, Sorbitol, Ethylenediaminetetraacetic acid, Sodium Metabisulphate and lipolytic enzyme.
- Complete removal of lipids from the lens is achieved by using a stabilised enzyme in fluid form and this may be applied either separately or as a second step. This is typically dripped onto the contact lens so as to remove any lipid deposits.
- The stabilised enzyme in fluid form is, as described above, preferably a lipase with a phosphate buffer.
- A further step in the cleaning operation involves rinsing the contact lens in a physiological saline solution and then boiling the lens in the same or a similar solution.
- The saline solution sould be particle-free (i.e. have a particle size below 0.2 micron), should be isotonic, should have a pH-value of 7.0 and buffer capacity of 6-8 and should also be sterile. The pH-value which is indicated is that value which will avoid smarting when the lens is subsequently inserted. An incorrect pH-value will cause smarting to occur. An incorrect pH-value will also cause the protein in the tear fluid to become denatured spontaneously which is not, of course, desirable.
- In order to fulfil the conditions imposed as to purity and sterility, the solution is preferably packed in a disposable pack and is sterilised by means of Gamma radiation.
- With a view to determining the cleansing effect of the solutions and method proposed by the invention, investigations were carried out as follows. For protein determination, the method according to Lowry as modified by Wedler was used. For determining the lipid quantity present, the method according to Boyer et al was used.
- Analysis of tear fluid according to several different sources shows that the fluid consists of Lysozyme, Ig y-gobulin, 1-lipoprotein, small amounts of carbohydrates and phospholipids. A similar solution was therefore prepared from the following:- y-chymotrypsin, serum albumin, lysozyme, bovine mucin, globulin II, A-globulin III, globulin and A-lipoprotein in 0.9% NaCI solution. Lenses were placed in this prepared solution and left over night. Control lenses were kept in a sterile saline solution instead of the prepared solution. At the end of the period of storage the lenses were divided into four groups:-
- Group 1. The lenses in this first groups were rinsed and then boiled in a sterile saline solution.
- Group 2. The lenses in the second group were rinsed in a "cleaning solution" and then stored in a saline solution containing preservatives.
- Group 3. The lenses in Group 3 were treated with an enzyme solution and subsequently rinsed and boiled.
- Group 4. The lenses from the saline solution were treated in the same way.
- After treatment the protein and lipid content of each of the four groups was found to be as follows:-
- Group 1-Protein content 3-8 yg per lens. Total lipid content 100―250 µg per lens.
- Group 2-Protein content 1―4 µg per lens. Lipid content 60-120,ug per lens.
- Group 3-Protein content 0―0.5 µg per lens. Lipid content 0-30 pg per lens.
- Group 4-Protein content 0.02 ,ug per lens. Lipid content 0 µg per lens.
- The invention allows soft contact lenses to be cleaned rapidly and effectively and in general the cleaning operation should be carried out daily. However, where lenses are worn day and night, the interval between cleanings may be extended to every other or even every third day.
- The invention therefore provides for a simpler cleaning process than the known technique which requires the dissolving of tablets in water and also provides for a shorter cleaning period than hitherto. What is more important, however, is that the invention allows a more complete cleaning of the contact lens on account of the higher enzymatic activity. Unlike previously known cleaning preparations, the method according to the present invention is also designed to be used daily on the one hand for cleaning the lenses and on the other hand as a preventative measure to prevent the build-up of larger deposits of protein and lipids which after a time are difficult to remove and affect the properties of the lens.
- The types of enzymes which can be utilised may be Papain or Bromelain in each case together with a lipolytic enzyme. Cysteine and Polysaccharides may be used as substrate materials.
- Enzymatic activity should be of the order of 100 tyrosine units per pg of protein (substrate).
- By splitting the albumin into water-soluble peptones by enzymatic action, the latter can be rinsed or boiled away using a physiological saline isotonic solution.
- The invention provides a stable liquid cleaning agent for cleaning soft contact lenses which can be stored under normal environmental conditions without loss of enzymatic activity thereby obviating the need to dissolve a tablet or quantity of powder in water so as to produce the cleaning solution for the lens. In this way just sufficient quantity of the cleaning liquid need be used to cover the surface of the lens and it is with this in mind that the invention provides for the application of the cleaning liquid by means of droplet applicator or the like.
- Typically the Prolen solution described above is used as a regular daily cleaning agent. This will remove most of the deposits normally found on the lens but will not completely remove the Lipid deposits.
Claims (14)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7804614A SE411152B (en) | 1978-04-21 | 1978-04-21 | WAY TO CLEAN SOFT CONTACT LENSES |
SE7804614 | 1978-04-21 | ||
GB3887378 | 1978-10-02 | ||
GB7838873A GB2019721B (en) | 1978-04-21 | 1978-10-02 | Method and materials for cleaning soft contact lenses |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0005131A2 EP0005131A2 (en) | 1979-10-31 |
EP0005131A3 EP0005131A3 (en) | 1979-11-28 |
EP0005131B1 true EP0005131B1 (en) | 1983-05-18 |
Family
ID=26269028
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP79850032A Expired EP0005131B1 (en) | 1978-04-21 | 1979-04-23 | Methods and materials for cleaning soft contact lenses |
EP79900454A Withdrawn EP0015968A1 (en) | 1978-04-21 | 1979-11-19 | Methods and materials for cleaning soft contact lenses |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP79900454A Withdrawn EP0015968A1 (en) | 1978-04-21 | 1979-11-19 | Methods and materials for cleaning soft contact lenses |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP0005131B1 (en) |
JP (1) | JPS55500262A (en) |
CH (1) | CH643663A5 (en) |
DE (1) | DE2965421D1 (en) |
FI (1) | FI791296A (en) |
NO (1) | NO153107C (en) |
WO (1) | WO1979000963A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4521254A (en) * | 1981-02-09 | 1985-06-04 | Anderson Ronald L | Cleaning contact lenses with solution of bromelain and carboxypeptidase |
EP0093784B1 (en) * | 1982-04-23 | 1987-08-05 | Dr. Thilo & Co. GmbH | Enzymatic contact lens cleaning product with ph-controlled activity |
US4614549A (en) * | 1983-10-24 | 1986-09-30 | Bausch & Lomb Incorporated | Method for enzymatic cleaning and disinfecting contact lenses |
CA1231069A (en) * | 1983-10-24 | 1988-01-05 | Bausch & Lomb Incorporated | Microbial enzymatic contact lens cleaner and methods of use |
US4690773A (en) * | 1983-10-24 | 1987-09-01 | Bausch & Lomb Incorporated | Microbial enzymatic contact lens cleaner and methods of use |
IE55711B1 (en) | 1983-10-24 | 1990-12-19 | Bausch & Lomb | Improved method for enzymatic cleaning and disinfecting contact lenses |
JPS62913A (en) * | 1985-06-26 | 1987-01-06 | Lion Corp | Cleaner for contact lens |
GB8629538D0 (en) † | 1986-12-10 | 1987-01-21 | Unilever Plc | Enzymatic dishwashing & rinsing composition |
GB8816443D0 (en) * | 1988-07-11 | 1988-08-17 | Albright & Wilson | Liquid enzymatic detergents |
JPH01180515A (en) * | 1988-01-13 | 1989-07-18 | Tome Sangyo Kk | Cleaning liquid and cleaning method for contact lens |
HU209538B (en) * | 1990-05-09 | 1994-07-28 | Vepex Contractor Ltd | Set and cleaning composition for treating contactlenses |
KR920007641A (en) * | 1990-10-25 | 1992-05-27 | 스기우라 켄이찌 | Contact Lens Solution |
GR1001126B (en) * | 1991-10-09 | 1993-04-28 | Tsakas Spyros Lavipharm Ae | Cleaning-sterilization of contact lenses via a new enzymatic and technical methodology |
BR9408502A (en) * | 1993-12-29 | 1997-08-05 | Bausch & Lomb | Composition for cleaning contact lenses Method for contact lenses of proteinaceous contaminants and method and composition for simultaneously cleaning and disinfecting contact lenses |
US20190382685A1 (en) | 2017-01-20 | 2019-12-19 | Albert Sturm | Contact lens cleaning agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855142A (en) * | 1971-07-15 | 1974-12-17 | Lever Brothers Ltd | Enzymatic denture cleanser |
US3910296A (en) * | 1973-04-20 | 1975-10-07 | Allergan Pharma | Method of removing proteinaceous deposits from contact lenses |
JPS5064303A (en) * | 1973-10-11 | 1975-05-31 | ||
US4096870A (en) * | 1977-06-09 | 1978-06-27 | Burton, Parsons And Company, Inc. | Method for cleaning soft hydrophilic gel contact lenses |
-
1979
- 1979-04-20 FI FI791296A patent/FI791296A/en not_active Application Discontinuation
- 1979-04-20 JP JP50072079A patent/JPS55500262A/ja active Pending
- 1979-04-20 NO NO791335A patent/NO153107C/en unknown
- 1979-04-20 WO PCT/SE1979/000097 patent/WO1979000963A1/en unknown
- 1979-04-20 CH CH1153779A patent/CH643663A5/en not_active IP Right Cessation
- 1979-04-23 EP EP79850032A patent/EP0005131B1/en not_active Expired
- 1979-04-23 DE DE7979850032T patent/DE2965421D1/en not_active Expired
- 1979-11-19 EP EP79900454A patent/EP0015968A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NO153107C (en) | 1986-01-15 |
CH643663A5 (en) | 1984-06-15 |
FI791296A (en) | 1979-10-22 |
DE2965421D1 (en) | 1983-07-07 |
EP0015968A1 (en) | 1980-10-01 |
EP0005131A3 (en) | 1979-11-28 |
NO791335L (en) | 1979-10-23 |
JPS55500262A (en) | 1980-05-01 |
EP0005131A2 (en) | 1979-10-31 |
WO1979000963A1 (en) | 1979-11-15 |
NO153107B (en) | 1985-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0005131B1 (en) | Methods and materials for cleaning soft contact lenses | |
US4096870A (en) | Method for cleaning soft hydrophilic gel contact lenses | |
US4500441A (en) | Contact lens cleaning and storage composition | |
CA1270119B (en) | Polymeric scrub | |
US4493783A (en) | Cleaning agent for optical surfaces | |
CA1284960C (en) | Solution and method for removing inorganic and organic deposits from contact lenses | |
US4521254A (en) | Cleaning contact lenses with solution of bromelain and carboxypeptidase | |
KR20050084241A (en) | Absorption and controlled release of polyethers from hydrogel biomaterials | |
EP0093784B1 (en) | Enzymatic contact lens cleaning product with ph-controlled activity | |
US5037484A (en) | Cleaning agent for optical surfaces | |
US4613379A (en) | Cleaning agent for optical surfaces | |
Nagaoka et al. | Inactivation of phagocytosis-stimulating activity of tuftsin by polymorphonuclear neutrophils: A possible role of leucine aminopeptidase as an ecto-enzyme | |
US4921630A (en) | Contact lens cleaning compositions containing an enzyme and a carboxy vinyl polymer | |
EP1845405A1 (en) | Liquid agent composition for contact lens | |
US4792414A (en) | Cleaning agent for optical surfaces | |
JPH01180515A (en) | Cleaning liquid and cleaning method for contact lens | |
JPS6359123B2 (en) | ||
CA1231069A (en) | Microbial enzymatic contact lens cleaner and methods of use | |
CA1146881A (en) | Methods and materials for cleaning soft contact lenses | |
EP0437179B1 (en) | PH-controlled protein removing cleaner | |
US5328846A (en) | Method for removing exogenous deposits from hydrophilic contact lenses | |
JP2000347142A (en) | Cleaning and preserving liquid agent for contact lens | |
JPH04143718A (en) | Dirt removing agent for contact lens | |
US4670060A (en) | Cleaning agent for optical surfaces | |
GB2029225A (en) | Method and materials for cleaning soft contact lenses. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR IT LU NL SE |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR IT LU NL SE |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR IT LU NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 19830518 Ref country code: CH Effective date: 19830518 |
|
REF | Corresponds to: |
Ref document number: 2965421 Country of ref document: DE Date of ref document: 19830707 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19840314 Year of fee payment: 6 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19840330 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19840331 Year of fee payment: 6 Ref country code: BE Payment date: 19840331 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19840430 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19840430 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19840525 Year of fee payment: 6 |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19850424 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Effective date: 19850430 |
|
BERE | Be: lapsed |
Owner name: BEDDING PETER MICHAEL JOHN Effective date: 19850423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19851101 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19851230 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19860101 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
EUG | Se: european patent has lapsed |
Ref document number: 79850032.8 Effective date: 19860128 |